We are live on ! Find out more
FLC

Fifth Lane Capital Portfolio holdings

AUM $1.63M
1-Year Est. Return 7.5%
This Fund
S&P 500
This Quarter Est. Return
+1.36%
1 Year Est. Return
+7.5%
3 Year Est. Return
+79.98%
5 Year Est. Return
10 Year Est. Return
AUM
$69M
AUM Growth
-$46.8M
Cap. Flow
-$44.1M
Cap. Flow %
-63.84%
Top 10 Hldgs %
68.54%
Holding
205
New
60
Increased
9
Reduced
11
Closed
93

Sector Composition

Rank Sector Weight
1 Financials 13.12%
2 Healthcare 6.81%
3 Consumer Discretionary 3.35%
4 Utilities 2.6%
5 Technology 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OKLO
176
CALL
Oklo
OKLO
$7.34B
-10,000
Closed -$114K
OKLO
177
Oklo
OKLO
$7.34B
-150,000
Closed -$1.71M
OKUR
178
OnKure Therapeutics
OKUR
$168M
-3,264
Closed -$54.2K
CTLT
179
CALL
DELISTED
CATALENT, INC.
CTLT
-500
Closed -$28.2K
SAVE
180
CALL
DELISTED
Spirit Airlines, Inc.
SAVE
-90,000
Closed -$436K
AXNX
181
DELISTED
Axonics, Inc. Common Stock
AXNX
-80,000
Closed -$5.52M
LLAP
182
DELISTED
Terran Orbital Corporation
LLAP
-60,968
Closed -$79.9K
EVA
183
CALL
DELISTED
Enviva Inc.
EVA
-224,000
Closed -$4.28M
HA
184
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
-28,800
Closed -$384K
ALIM
185
DELISTED
Alimera Sciences
ALIM
-21,238
Closed -$82.8K
HOLI
186
PUT
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-10,900
Closed -$279K
BWAQ
187
DELISTED
Blue World Acquisition Corporation Class A Ordinary Shares
BWAQ
-20,000
Closed -$224K
HRT
188
DELISTED
HireRight Holdings Corporation
HRT
-100,000
Closed -$1.43M
RWODR
189
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
-51,900
Closed -$11.5K
FUSN
190
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-16,000
Closed -$341K
FUSN
191
PUT
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-25,000
Closed -$533K
DOOR
192
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
-7,244
Closed -$952K
SCRM
193
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
-110,740
Closed -$52.3K
AIBBR
194
DELISTED
AIB Acquisition Corp Right
AIBBR
-200,240
Closed -$26.1K
IBACU
195
DELISTED
IB Acquisition Corp. Unit
IBACU
-300,000
Closed -$3M
MBTCR
196
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
-28,700
Closed -$4.71K
ASCAR
197
DELISTED
A SPAC I Acquisition Corp. Right
ASCAR
-110,000
Closed -$20.9K
MCAFR
198
DELISTED
Mountain Crest Acquisition Corp. IV Rights
MCAFR
-225,997
Closed -$42.8K
CPE
199
DELISTED
Callon Petroleum Company
CPE
-524,908
Closed -$18.8M
PARAP
200
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
-40,000
Closed -$550K

Similar funds

Fifth Lane Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Fifth Lane Capital held 205 positions worth $69M, down 40% from $116M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Fifth Lane Capital withdrew a net $44.1M in Q2 2024, closing 93 positions and reducing 11 holdings. Its most notable exit was Callon Petroleum Company, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Fifth Lane Capital opened a new position in Merck worth $3.71M.

  • Fifth Lane Capital's largest Q2 2024 buy was Merck: 30,000 shares worth $3.71M.
  • Fifth Lane Capital added most to Investcorp Europe Acquisition Corp I Class A Ordinary Shares in Q2 2024, an estimated $5.36M increase.
  • Fifth Lane Capital's biggest Q2 2024 reduction was Signature Bank Depositary shares, each representing a 1/40th ownership interest in a share of 5.000% Noncumulative Perpetual Series A Preferred Stock, cutting an estimated $604K.
  • Fifth Lane Capital fully exited Callon Petroleum Company in Q2 2024, selling an estimated $18.8M.
  • Fifth Lane Capital's ten largest holdings make up 69% of its $69M portfolio in Q2 2024.
  • Fifth Lane Capital opened 60 new positions and closed 93 in Q2 2024.
  • Fifth Lane Capital's portfolio value fell 40% quarter-over-quarter to $69M.

Based on Fifth Lane Capital's 13F filing for Q2 2024, filed 14 Aug 2024.